Medical News Today: Rheumatoid arthritis: Birth control pill tied to reduced risk
A large Swedish study has found that women who had used contraceptive pills had less risk of developing rheumatoid arthritis than women who had not. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 18, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Arthritis diet: The SIX foods to avoid if you suffer painful symptoms
RHEUMATOID arthritis is a long-term condition that causes pain, swelling and stiffness in the joints and mainly affects the hands feet and wrists. (Source: Daily Express - Health)
Source: Daily Express - Health - August 18, 2017 Category: Consumer Health News Source Type: news

Contraceptive pill linked to reduced risk of rheumatoid arthritis
Taking oral contraceptive for seven or more consecutive years is linked to a 19% lower risk of developing rheumatoid arthritis (RA), according to researchers. (Source: GP Online News)
Source: GP Online News - August 18, 2017 Category: Primary Care Tags: 10.1 Women's Health Source Type: news

Taking the pill for seven years could reduce arthritis risk by 19%
No protective effect found from breastfeeding Related items fromOnMedica Rheumatoid arthritis Breastfeeding may halve rheumatoid arthritis risk Obese women on the pill more likely to have rare stroke Contraceptive pill appears to protect from cancers for up to 30 years Oral contraceptive pill impacts on wellbeing (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 18, 2017 Category: UK Health Source Type: news

Lab tests show molecule appears to spur cell death in tumors, inflammation
(Duke University Medical Center) A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 17, 2017 Category: Cancer & Oncology Source Type: news

Some jobs tied to higher risk of rheumatoid arthritis
(Reuters Health) - Workers exposed to airborne toxins may have an elevated risk of developing rheumatoid arthritis, an immune system disorder that causes debilitating swelling and pain in the joints, a Swedish study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Does Lipitor Help Rheumatoid Arthritis?
Title: Does Lipitor Help Rheumatoid Arthritis?Category: Doctor's& Expert's views on SymptomsCreated: 8/15/2017 12:00:00 AMLast Editorial Review: 8/15/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 15, 2017 Category: Rheumatology Source Type: news

Female HCAs at 'slightly higher risk of rheumatoid arthritis'
Being a healthcare assistant may put women at slightly higher risk of developing rheumatoid arthritis than the rest of the population, including registered nurses, a study has suggested. (Source: Nursing Times)
Source: Nursing Times - August 11, 2017 Category: Nursing Source Type: news

Certain Jobs Linked to Raised Risk of Rheumatoid Arthritis
Title: Certain Jobs Linked to Raised Risk of Rheumatoid ArthritisCategory: Health NewsCreated: 8/10/2017 12:00:00 AMLast Editorial Review: 8/11/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 11, 2017 Category: Rheumatology Source Type: news

Scientists make critical insights into T-cell development
(Monash University) Mutations in the gene encoding the enzyme protein tyrosine phosphatase N2 (PTPN2) have been associated with the development of autoimmune disease including Type 1 diabetes, Crohn's Disease and rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 11, 2017 Category: International Medicine & Public Health Source Type: news

Certain jobs linked to raised risk of rheumatoid arthritis
Rheumatoid arthritis appears to be more common among people in certain types of jobs, researchers suggest. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 11, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis risk 'may be elevated for people in certain jobs'
This study, published in the medical journal Arthritis Research& Care, assessed data from 3,522 Swedish individuals with rheumatoid arthritis and 5,580 control subjects, including information on environmental, genetic and immunological factors between 1996 and 2014. Male workers in the manufacturing sector were shown to have a higher risk of developing rheumatoid arthritis than those working in professional, administrative and technical roles, with electrical and electronics workers and material handling operators experiencing a twofold increased risk, while bricklayers and concrete workers were three times more likely...
Source: Arthritis Research UK - August 10, 2017 Category: Rheumatology Source Type: news

Occupational Exposures Increase Rheumatoid Arthritis Risk Occupational Exposures Increase Rheumatoid Arthritis Risk
Workers in certain occupations were at increased risk of developing arthritis, a population-based cohort study has found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Certain Jobs Linked to Raised Risk of Rheumatoid Arthritis
Risk was doubled among men who did electrical work, and tripled among bricklayers, study finds Source: HealthDay Related MedlinePlus Pages: Occupational Health, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 10, 2017 Category: Consumer Health News Source Type: news

Certain Jobs Linked to Raised Risk of Rheumatoid Arthritis
THURSDAY, Aug. 10, 2017 -- Rheumatoid arthritis, a painful disease in which a person's immune system attacks the joints, appears to be more common among people in certain types of jobs, researchers suggest. The findings " indicate that work-related... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 10, 2017 Category: General Medicine Source Type: news

Arthritis warning: THIS common medication could be linked to deadly liver failure
ARTHRITIS causes symptoms including painful joints and stiffness. One type, rheumatoid arthritis, is often treated with medications that reduce discomfort - but the side effects of the drug methotrexate, can include liver failure. (Source: Daily Express - Health)
Source: Daily Express - Health - August 10, 2017 Category: Consumer Health News Source Type: news

Certain occupations linked to an increased risk of rheumatoid arthritis
(Wiley) New research indicates that certain occupations may put workers at an elevated risk of developing rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 10, 2017 Category: International Medicine & Public Health Source Type: news

Certain occupations linked to increased risk of rheumatoid arthritis
Male manufacturing workers, bricklayers and concrete workers are at particularly high risk Related items fromOnMedica Fibre-rich diet linked to lowered risk of painful knee osteoarthritis Fibre-rich diet linked to lowered risk of painful knee osteoarthritis Chondroitin sulfate as good as widely used anti-inflammatory for knee osteoarthritis Rheumatoid arthritis Obesity may skew results of rheumatoid arthritis blood tests in women (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 10, 2017 Category: UK Health Source Type: news

Rheumatoid arthritis - symptoms will not improve if patients do THIS
RHEUMATOID arthritis is a serious and disabling autoimmune disease in which the immune system mistakenly attacks and destroys healthy body tissue. (Source: Daily Express - Health)
Source: Daily Express - Health - August 9, 2017 Category: Consumer Health News Source Type: news

Finger prick test allows patients taking autoimmune drug to avoid blood draws
(Wiley) A new study shows that patients with rheumatoid arthritis and other autoimmune conditions who take the drug adalimumab can monitor drug levels in their bodies with a finger prick rather than undergoing a full blood draw. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news

Insights tying bone cells to rheumatoid arthritis
An EU-funded project has generated new insights into the causes and development of rheumatoid arthritis, directing efforts towards earlier detection, prevention and the idea of inducing tolerance to this chronic and debilitating disease. Follow-up reearch includes new studies to further explore this 'tolerance' challenge and progress on a new antibody detecting device. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - August 7, 2017 Category: Research Source Type: news

Sirukumab Not Recommended for RA on Mortality Concerns Sirukumab Not Recommended for RA on Mortality Concerns
An FDA panel voted not to recommend sirukumab for adults with moderate-to-severe rheumatoid arthritis because of increased mortality in patients who took the drug in clinical trials.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 2, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Fda advisory committee does not recommend approval of sirukumab for the treatment of moderately to severely active rheumatoid arthritis
(Source: Johnson and Johnson)
Source: Johnson and Johnson - August 2, 2017 Category: Pharmaceuticals Source Type: news

FDA panel votes against approval of J & J arthritis drug
(Reuters) - The benefits of Johnson& Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks and it should not be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - August 2, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Advisory Committee Does Not Recommend Approval of Sirukumab for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
HORSHAM, Pa., Aug. 2, 2017 /PRNewswire/ -- Janssen Biotech, Inc. announced today that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) did not recommend approval of sirukumab (proposed trade name PLIVENSIA ™) for the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 2, 2017 Category: Drugs & Pharmacology Source Type: news

Solomon Awarded FNIH Grant to Study Rheumatoid Arthritis Biomarkers
Daniel Solomon, MD, MPH, of the Division of Rheumatology, received a four-year, $850,000 grant from the Foundation for the National Institutes of Health (FNIH) to support his research that contributes to the FNIH TARGET Biomarker study. (Source: BWH News)
Source: BWH News - August 2, 2017 Category: Hospital Management Source Type: news

J & J Arthritis Drug Sirukumab Raises Safety Concerns -FDA Staff J & J Arthritis Drug Sirukumab Raises Safety Concerns -FDA Staff
There were more deaths in patients taking Johnson and Johnson's experimental rheumatoid arthritis drug sirukumab than among those taking a placebo, staff reviewers for the U.S. Food and Drug Administration said in a report published Monday.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 1, 2017 Category: Allergy & Immunology Tags: Pharmacist News Source Type: news

Pfizer revenue misses on lower Prevnar, Enbrel sales
(Reuters) - Pfizer Inc reported quarterly revenue on Tuesday that missed Wall Street estimates, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Pfizer quarterly revenue slips 2 percent
(Reuters) - Pfizer Inc reported a nearly 2 percent drop in quarterly revenue on Tuesday, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

J & J arthritis drug sirukumab raises safety concerns: FDA staff
(Reuters) - Staff reviewers for the U.S. Food and Drug Administration noted on Monday that there was a trend of increased death with Johnson& Johnson's experimental rheumatoid arthritis drug sirukumab compared with placebo. (Source: Reuters: Health)
Source: Reuters: Health - July 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: Gold injections: Can they treat rheumatoid arthritis?
What are gold injections and can they be used to treat rheumatoid arthritis? How are gold treatments administered and what may the side effects be? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 31, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Immune system warning: These five conditions are because of inflammation
IMMUNE systems are designed to protect us, but sometimes the inflammation they trigger to fight off foreign substances goes wrong - and we ’re left with asthma, rheumatoid arthritis and a number of other conditions. (Source: Daily Express - Health)
Source: Daily Express - Health - July 30, 2017 Category: Consumer Health News Source Type: news

AbbVie's profit beats on Humira, Imbruvica demand
(Reuters) - U.S. drugmaker AbbVie Inc reported quarterly earnings on Friday that edged past analysts' expectations, helped by robust demand for its flagship rheumatoid arthritis drug, Humira. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie's profit beats on robust Humira demand
(Reuters) - U.S. drugmaker AbbVie Inc reported quarterly earnings on Friday that edged past analysts' expectations, helped by robust demand for its flagship rheumatoid arthritis drug, Humira. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie's profit rises 19 percent on Humira demand
(Reuters) - U.S. drugmaker AbbVie Inc reported an 18.9 percent rise in quarterly profit on Friday on strong demand for its flagship rheumatoid arthritis drug, Humira. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Arthritis symptoms: Would YOU be able to spot these five RARE types?
ARTHRITIS is a disease causing inflammation and stiffness in the joints. Despite their prevalence, osteoarthritis and rheumatoid arthritis are not the only types - would you be able to spot the symptoms of these rarer forms? (Source: Daily Express - Health)
Source: Daily Express - Health - July 26, 2017 Category: Consumer Health News Source Type: news

Lilly signals long delay for arthritis drug, shares fall
(Reuters) - Eli Lilly and Co on Tuesday outlined a likely multi-year delay for its experimental rheumatoid arthritis drug with blockbuster sales potential, and disappointed investors sent its shares down nearly 4 percent. (Source: Reuters: Health)
Source: Reuters: Health - July 25, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Merck, Samsung Bioepis launch discounted U.S. Remicade alternative
NEW YORK/SEOUL (Reuters) - Merck& Co and South Korea's Samsung Bioepis Co Ltd said on Monday they have begun selling a less expensive alternative version of Johnson& Johnson's rheumatoid arthritis drug Remicade in the United States, a move that should accelerate price declines for the big-selling medicine. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Merck launches biosimilar version of J & J blockbuster Remicade
Merck and Co. Inc. on Monday became the second pharmaceutical company to launch a biosimilar version of Remicade, a drug that generates billions of dollars a year in sales for Johnson& Johnson. Renflexis, the Merck biosimilar product, was approved by the Food and Drug Administration on April 21 as a treatment for rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis. It is the first medicine available in the United States under a global biosimilars develop ment and… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 24, 2017 Category: Health Management Authors: John George Source Type: news

Samsung Bioepis launches U.S. sales of Remicade biosmiliar
SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said it started U.S sales of its copy of Johnson& Johnson's rheumatoid arthritis drug Remicade on Monday - a move set to further undermine sales of the U.S. firm's top-selling drug. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

New video: Patient and researcher fight JRA together
Have you ever heard ofjuvenile rheumatoid arthritis (JRA)? A lot of people haven ’t. (Source: The Catalyst)
Source: The Catalyst - July 19, 2017 Category: Pharmaceuticals Source Type: news

Cardiovascular Imaging in the Assessment of CV Risk in RA Cardiovascular Imaging in the Assessment of CV Risk in RA
Find out which imaging techniques may play a role in the cardiovascular risk stratification of patients with rheumatoid arthritis.Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Singapore scientists pave way for better juvenile arthritis diagnosis & treatment outcome prediction
(SingHealth) They discovered a previously unknown group of regulatory T cells linked to the disease and DNA features that affect patients' response to treatment.Findings pave the way for improved juvenile arthritis diagnosis and prediction of treatment outcomes, and are also relevant for adult rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2017 Category: International Medicine & Public Health Source Type: news

Arthritis treatment - are you worred about THESE side effects of drugs?
RHEUMATOID arthritis is a condition which can be treated with painkillers or non steroidal anti inflammatories. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2017 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis vs. Fibromyalgia
Title: Rheumatoid Arthritis vs. FibromyalgiaCategory: Diseases and ConditionsCreated: 7/5/2017 12:00:00 AMLast Editorial Review: 7/5/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 5, 2017 Category: Rheumatology Source Type: news

Lilly and Incyte receive marketing approval for RA treatment Olumiant in Japan
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing approval for Olumiant (baricitinib) 2mg and 4mg tablets for the treatment of rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 4, 2017 Category: Pharmaceuticals Source Type: news

Japan Ministry of Health, Labor and Welfare (MHLW) Grants Marketing Approval For Olumiant(R) (baricitinib) for the Treatment of Rheumatoid Arthritis
INDIANAPOLIS, July 3, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that Japan's Ministry of Health, Labor and Welfare (MHLW) granted marketing approval for Olumia... Biopharmaceuticals, Regulatory Eli Lilly, Olumiant, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2017 Category: Pharmaceuticals Source Type: news

Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis
Sarilumab is indicated for adults with moderate to severe active rheumatoid arthritis who fail or are intolerant to disease-modifying antirheumatic drugs.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Improving VNS therapy: ElectroCore CEO Amato on gammaCore and its slated July launch
Neuroscience tech developer ElectroCore said recently it plans to launch its handheld gammaCore vagus nerve stimulation device in the US in mid-July, after having won clearance from the FDA in April for treating episodic cluster headaches. Unlike other vagus nerve stimulation devices, the gammaCore is an external handheld device with no implanted component, designed to be used in a pain-free procedure, CEO Frank Amato told MassDevice.com in an interview. “Its a first-of-its-kind type of device,” Amato said, speaking on the recently approved and soon-to-launch gammaCore. “Vagus nerve stimulators have been ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Source Type: news